NLM Logo

atezolizumab MeSH Supplementary Concept Data 2023


MeSH Supplementary
atezolizumab
Unique ID
C000594389
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000594389
Entry Term(s)
MPDL-3280A
MPDL3280A
RG-7446
RG7446
Tecentriq
anti-PDL1
immunoglobulin G1, anti-(human CD antigen CD274) (human monoclonal MDPL3280a heavy chain), disulfide with human monoclonal MDPL3280a kappa-chain, dimer
Pharm Action
Immune Checkpoint Inhibitors
Antineoplastic Agents
Registry Number
52CMI0WC3Y
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
970
Note
A monoclonal antibody that targets programmed death-ligand 1 (CD274 ANTIGEN) and is used to treat urothelial carcinoma, the most common type of bladder cancer.
Source
Cancer Control. 2014 Jan;21(1):80-9.
Indexing Information
B7-H1 Antigen
Date of Entry
2015/01/11
Revision Date
2022/01/31
atezolizumab Preferred
MPDL3280A Narrower
Tecentriq Narrower
RG7446 Narrower
page delivered in 0.005s